About ATOM BIOWORKS INC
Atombio is a company focused on AI-driven nucleic acid design, offering platforms for mRNA, aptamers, and lipid nanoparticle (LNP) delivery. Founded in 2021, they aim to revolutionize programmable nucleic acid design for applications in medicine and bioengineering.
AI-driven nucleic acid designmRNA design via mRNAutilusAptamer discovery and optimization via AptaBLEProgrammable lipid nanoparticle (AptLNP) deliveryNo-code nucleic acid design through AutoNA platform
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ATOM BIOWORKS INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.